The global pet cancer therapeutics market is projected to rise by USD 251.0 million by 2028, according to a new report by Gen Consulting Company. It is anticipated to expand at a CAGR of 8.8 percent during the forecast period.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global pet cancer therapeutics market. It traces the market's historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors' approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the pet cancer therapeutics industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the therapy, type, application, and region. The global market for pet cancer therapeutics can be segmented by therapy: chemotherapy, radiation therapy, immunotherapy, targeted therapy, others. The targeted therapy segment held the largest revenue share in 2021. Pet cancer therapeutics market is further segmented by type: dog, cat, others. Among these, the dog segment was accounted for the highest revenue generator in 2021. Based on application, the pet cancer therapeutics market is segmented into: lymphoma, mast cell cancer, melanoma, others. The mast cell cancer segment captured the largest share of the market in 2021. On the basis of region, the pet cancer therapeutics market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. According to the research, North America had the largest share in the global pet cancer therapeutics market.
Market Segmentation
By therapy: chemotherapy, radiation therapy, immunotherapy, targeted therapy, others
By type: dog, cat, others
By application: lymphoma, mast cell cancer, melanoma, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The report has also analysed the competitive landscape of the global pet cancer therapeutics market with some of the key players being AB Science SA, Boehringer Ingelheim GmbH, Dechra Pharmaceuticals plc, Elanco Animal Health Incorporated, Elekta, Karyopharm Therapeutics Inc., Oasmia Pharmaceutical AB, Virbac, Zoetis, Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global pet cancer therapeutics market.
- To classify and forecast the global pet cancer therapeutics market based on therapy, type, application, region.
- To identify drivers and challenges for the global pet cancer therapeutics market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global pet cancer therapeutics market.
- To identify and analyze the profile of leading players operating in the global pet cancer therapeutics market.
Why Choose This Report
- Gain a reliable outlook of the global pet cancer therapeutics market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY THERAPY
· Chemotherapy
· Radiation therapy
· Immunotherapy
· Targeted therapy
· Others
PART 6. MARKET BREAKDOWN BY TYPE
· Dog
· Cat
· Others
PART 7. MARKET BREAKDOWN BY APPLICATION
· Lymphoma
· Mast cell cancer
· Melanoma
· Others
PART 8. MARKET BREAKDOWN BY REGION
· North America
· Europe
· Asia-Pacific
· MEA (Middle East and Africa)
· Latin America
PART 9. KEY COMPANIES
· AB Science SA
· Boehringer Ingelheim GmbH
· Dechra Pharmaceuticals plc
· Elanco Animal Health Incorporated
· Elekta
· Karyopharm Therapeutics Inc.
· Oasmia Pharmaceutical AB
· Virbac
· Zoetis, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Overview of the Global Advanced Cancer Care Coordination Market:
The report discusses everything a marketer requires before investing in the global Advanced Cancer Care Coordination Market during the forecast period...
Overview of the Global Online Cancer Patient Registry Software Market:
The report discusses everything a marketer requires before investing in the global Online Cancer Patient Registry Software Market during the for...
Overview of the Global Cancer Pain Management Software Market:
The report discusses everything a marketer requires before investing in the global Cancer Pain Management Software Market during the forecast period 202...
Overview of the Global Holistic Mindfulness Cancer Care Management Market:
The report discusses everything a marketer requires before investing in the global Holistic Mindfulness Cancer Care Management Market during...
Overview of the Global Cancer Registry Management Solutions Market:
The report discusses everything a marketer requires before investing in the global Cancer Registry Management Solutions Market during the forecast ...
Overview of the Global Cancer Registry Quality Control Software Market:
The report discusses everything a marketer requires before investing in the global Cancer Registry Quality Control Software Market during the f...
Overview of the Global Early Cancer Screening Technologies Market:
The report discusses everything a marketer requires before investing in the global Early Cancer Screening Technologies Market during the forecast pe...
Overview of the Global Advanced Therapeutics Pharmaceutical Outsourcing Market:
The report discusses everything a marketer requires before investing in the global Advanced Therapeutics Pharmaceutical Outsourcing Mar...
Overview of the Global ESR1 Mutated Metastatic Breast Cancer Diagnostics Market:
The report discusses everything a marketer requires before investing in the global ESR1 Mutated Metastatic Breast Cancer Diagnostics M...
Description
Artificial intelligence is increasingly permeating cancer diagnostics through sophisticated algorithms capable of deriving insights from vast, multifaceted medical datasets. AI leverages machine learning to recognize patterns across imaging, genomic sequencing, electronic health re...